大洋生物：预计前三季度净利润同比增长44.35%—75.56%

Core Viewpoint - The company, Dayang Biological (003017.SZ), expects a significant increase in net profit for the first three quarters, driven by rising demand for its main products, potassium carbonate and veterinary raw materials, due to market influences [1] Financial Performance - The net profit attributable to shareholders is projected to be between 74 million and 90 million yuan, representing a year-on-year growth of 44.35% to 75.56% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 67 million and 82 million yuan, indicating a growth of 39.04% to 70.17% compared to the same period last year [1] Market Dynamics - The increase in net profit is attributed to higher sales volumes and prices of the company's main products, along with an improvement in gross profit margins [1]